BRIEF-Psivida Corp says first Phase 3 trial of Medidur continued to meet primary endpoint
July 27, 2016 at 07:44 AM EDT
* First phase 3 trial of medidur for treatment of posterior uveitis continued to meet its primary endpoint Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1-646-223-8780)